Circulating dipeptidyl peptidase 3 and outcomes in acute heart failure: an analysis of the STRONG-HF and CORTAHF studies. [PDF]
Bruno J +10 more
europepmc +1 more source
Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation. [PDF]
Chiang YL +5 more
europepmc +1 more source
Association of GLP-1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program. [PDF]
Hwang I, Kim Y, Lee SW.
europepmc +1 more source
Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. [PDF]
Hong SH +7 more
europepmc +1 more source
Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease. [PDF]
Seo DH, Ha KH, Kim SH, Kim DJ.
europepmc +1 more source
Repurposing dipeptidyl peptidase-4 inhibitor for Parkinson's disease prevention: A drug-target Mendelian randomization study. [PDF]
Lee JY, Park DG, Sung J.
europepmc +1 more source
Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. [PDF]
Kawamoto H +4 more
europepmc +1 more source
The role of DPP4 in viral infections: from receptor biology to antiviral target. [PDF]
Aguilera-Flores C, Arias CF.
europepmc +1 more source
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes. [PDF]
Chen YH +8 more
europepmc +1 more source
Comparative Clinical Analysis of DPP-4 inhibitors and SGLT2 Inhibitors: A Real-World Switch Study. [PDF]
Choe HJ +4 more
europepmc +1 more source

